Annexon biosciences reports fourth quarter and full-year 2020 financial results with recent business highlights

South san francisco, calif., march 25, 2021 (globe newswire) -- today annexon, inc. (“annexon”) (nasdaq: annx), a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain and eye, announced fourth quarter and full-year 2020 financial results and business highlights.
ANNX Ratings Summary
ANNX Quant Ranking